36012389|t|Functional Crosstalk between PCSK9 Internalization and Pro-Inflammatory Activation in Human Macrophages: Role of Reactive Oxygen Species Release.
36012389|a|Atherosclerosis is a cardiovascular disease caused mainly by dyslipidemia and is characterized by the formation of an atheroma plaque and chronic inflammation. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a protease that induces the degradation of the LDL receptor (LDLR), which contributes to increased levels of LDL cholesterol and the progress of atherosclerosis. Given that macrophages are relevant components of the lipidic and inflammatory environment of atherosclerosis, we studied the effects of PCSK9 treatment on human macrophages. Our data show that human macrophages do not express PCSK9 but rapidly incorporate the circulating protein through the LDLR and also activate the pro-inflammatory TLR4 pathway. Both LDLR and TLR4 are internalized after incubation of macrophages with exogenous PCSK9. PCSK9 uptake increases the production of reactive oxygen species and reduces the expression of genes involved in lipid metabolism and cholesterol efflux, while enhancing the production of pro-inflammatory cytokines through a TLR4-dependent mechanism. Under these conditions, the viability of macrophages is compromised, leading to increased cell death. These results provide novel insights into the role of PCSK9 in the crosstalk of lipids and cholesterol metabolism through the LDLR and on the pro-inflammatory activation of macrophages through TLR4 signaling. These pathways are relevant in the outcome of atherosclerosis and highlight the relevance of PCSK9 as a therapeutic target for the treatment of cardiovascular diseases.
36012389	29	34	PCSK9	Gene	255738
36012389	59	71	Inflammatory	Disease	MESH:D007249
36012389	86	91	Human	Species	9606
36012389	113	136	Reactive Oxygen Species	Chemical	MESH:D017382
36012389	146	161	Atherosclerosis	Disease	MESH:D050197
36012389	167	189	cardiovascular disease	Disease	MESH:D002318
36012389	207	219	dyslipidemia	Disease	MESH:D050171
36012389	264	272	atheroma	Disease	MESH:D058226
36012389	284	304	chronic inflammation	Disease	MESH:D007249
36012389	306	351	Proprotein convertase subtilisin/kexin type 9	Gene	255738
36012389	353	358	PCSK9	Gene	255738
36012389	410	422	LDL receptor	Gene	3949
36012389	424	428	LDLR	Gene	3949
36012389	508	523	atherosclerosis	Disease	MESH:D050197
36012389	591	603	inflammatory	Disease	MESH:D007249
36012389	619	634	atherosclerosis	Disease	MESH:D050197
36012389	662	667	PCSK9	Gene	255738
36012389	681	686	human	Species	9606
36012389	719	724	human	Species	9606
36012389	752	757	PCSK9	Gene	255738
36012389	818	822	LDLR	Gene	3949
36012389	849	861	inflammatory	Disease	MESH:D007249
36012389	862	866	TLR4	Gene	7099
36012389	881	885	LDLR	Gene	3949
36012389	890	894	TLR4	Gene	7099
36012389	959	964	PCSK9	Gene	255738
36012389	966	971	PCSK9	Gene	255738
36012389	1007	1030	reactive oxygen species	Chemical	MESH:D017382
36012389	1079	1084	lipid	Chemical	MESH:D008055
36012389	1100	1111	cholesterol	Chemical	MESH:D002784
36012389	1158	1170	inflammatory	Disease	MESH:D007249
36012389	1191	1195	TLR4	Gene	7099
36012389	1373	1378	PCSK9	Gene	255738
36012389	1399	1405	lipids	Chemical	MESH:D008055
36012389	1410	1421	cholesterol	Chemical	MESH:D002784
36012389	1445	1449	LDLR	Gene	3949
36012389	1465	1477	inflammatory	Disease	MESH:D007249
36012389	1512	1516	TLR4	Gene	7099
36012389	1574	1589	atherosclerosis	Disease	MESH:D050197
36012389	1621	1626	PCSK9	Gene	255738
36012389	1672	1695	cardiovascular diseases	Disease	MESH:D002318
36012389	Negative_Correlation	255738	3949
36012389	Association	MESH:D050197	3949
36012389	Association	MESH:D017382	255738
36012389	Association	255738	7099
36012389	Negative_Correlation	MESH:D002784	255738
36012389	Association	MESH:D007249	255738
36012389	Association	MESH:D008055	3949
36012389	Association	MESH:D007249	7099
36012389	Association	MESH:D050197	255738
36012389	Association	MESH:D002784	3949
36012389	Negative_Correlation	MESH:D008055	255738
36012389	Association	MESH:D002318	255738

